Lipid-based nanoparticle innovation is advancing at lightning speed, especially priorities in achieving precise delivery beyond the liver.
Join our CSO, Corwin Nycholat, at the 4th Annual Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit, taking place June 24–26, 2025, at the Hilton Boston Back Bay.
At Sussex Research Laboratories Inc., we’re excited to share our industry leading expertise in glycan-based solutions that enable targeted extra-hepatic delivery of therapeutic payloads, including RNA, proteins, lipids, small molecules and their associated LNP delivery systems.
Let’s connect and shape the future of targeted therapeutics!
4th Annual Extra-Hepatic Lipid-Based Nanoparticles Delivery Summit
